Skip to content

Fecal Lactate and Resuscitation Outcomes in Critical Illness

Prognostic Value of Fecal Lactate and the Fecal-to-Serum Lactate Gradient in Resuscitation Response Among Critically Ill Patients With Tissue Hypoperfusion: A Prospective Pilot Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07658001
Acronym
DELTA-LAC
Enrollment
40
Registered
2026-06-18
Start date
2026-04-06
Completion date
2026-12-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Sepsis, Shock, Tissue Hypoperfusion

Keywords

Fecal Lactate, Lactate Gradient, Splanchnic Hypoperfusion, Intensive Care Unit, Biomarkers

Brief summary

This study evaluates the prognostic value of fecal lactate and the fecal-to-serum lactate gradient as early biomarkers of tissue hypoperfusion in critically ill patients. While serum lactate is widely used, it may not accurately reflect splanchnic perfusion. This prospective observational study aims to determine whether fecal lactate levels obtained within the first 12-24 hours can predict poor response to resuscitation at 24 hours. The primary outcome is a composite of increased vasopressor requirements, persistent hyperlactatemia, worsening organ dysfunction, or death.

Detailed description

Tissue hypoperfusion is a central mechanism in the development of organ dysfunction in critically ill patients. Although serum lactate is commonly used as a marker of hypoxia and a target for resuscitation, it may not adequately reflect regional perfusion, particularly in the splanchnic circulation. Persistent splanchnic hypoperfusion contributes to intestinal barrier dysfunction, bacterial translocation, and progression to multiple organ failure. This study is based on the hypothesis that, under ischemic conditions, the intestinal mucosa behaves as a semipermeable membrane, allowing equilibration of lactate produced in the intestinal wall into the lumen. Therefore, fecal lactate may serve as a direct and early marker of intestinal hypoperfusion. This is a prospective, observational, single-center cohort study conducted in an intensive care unit. Adult patients (≥18 years) with evidence of tissue hypoperfusion will be included. Fecal samples will be collected within the first 12-24 hours and processed through dilution, homogenization, centrifugation, and colorimetric analysis of the supernatant to quantify L-lactate levels. Simultaneously, serum lactate will be measured, and the fecal-to-serum lactate gradient will be calculated. The primary outcome is poor response to resuscitation at 24 hours, defined as a composite endpoint including increased vasopressor requirements, serum lactate clearance \<10% or persistent lactate \>2 mmol/L, worsening organ dysfunction measured by SOFA score (increase ≥1 point), or death. Secondary objectives include evaluating the correlation between fecal lactate and organ dysfunction severity, as well as determining the optimal cut-off value for fecal lactate to predict adverse outcomes using receiver operating characteristic (ROC) curve analysis. This study aims to identify fecal lactate as a non-invasive, early, and specific biomarker of splanchnic hypoperfusion, potentially improving clinical decision-making and guiding resuscitation strategies in critically ill patients.

Interventions

None listed

Sponsors

Hospital H+ Queretaro
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients ≥18 years admitted to the intensive care unit (ICU) * Evidence of tissue hypoperfusion defined by at least ONE of the following: Arterial serum lactate ≥2.0 mmol/L or Hypotension requiring vasopressors to maintain mean arterial pressure (MAP) ≥65 mmHg * Clinical signs of hypoperfusion (capillary refill time \>3 seconds or mottling score ≥2) * Availability of fecal sample within the first 24 hours of ICU admission

Exclusion criteria

* Active gastrointestinal bleeding * Recent abdominal surgery (\<48 hours) with intestinal resection or stoma * Confirmed Clostridioides difficile infection * Do-not-resuscitate (DNR) orders at ICU admission

Design outcomes

Primary

MeasureTime frameDescription
Poor Response to Resuscitation at 24 Hours24 hoursComposite outcome defined by the presence of at least one of the following within 24 hours: increase in vasopressor requirements compared to baseline, serum lactate clearance \<10% or persistent lactate \>2 mmol/L, increase in SOFA score ≥1 point, or death.

Secondary

MeasureTime frameDescription
Correlation Between Fecal Lactate and Organ DysfunctionBaseline and 24 hoursAssessment of the association between fecal lactate levels and the severity of organ dysfunction measured by SOFA score at baseline and 24 hours.
Diagnostic Performance of Fecal Lactate for Predicting Poor Response24 hoursEvaluation of the predictive accuracy of fecal lactate levels for poor response to resuscitation using receiver operating characteristic (ROC) curve analysis and area under the curve (AUC).

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026